Cargando…

Introducing the EMPIRE Index: A novel, value-based metric framework to measure the impact of medical publications

Article-level measures of publication impact (alternative metrics or altmetrics) can help authors and other stakeholders assess engagement with their research and the success of their communication efforts. The wide variety of altmetrics can make interpretation and comparative assessment difficult;...

Descripción completa

Detalles Bibliográficos
Autores principales: Pal, Avishek, Rees, Tomas James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979442/
https://www.ncbi.nlm.nih.gov/pubmed/35377894
http://dx.doi.org/10.1371/journal.pone.0265381
_version_ 1784681176050434048
author Pal, Avishek
Rees, Tomas James
author_facet Pal, Avishek
Rees, Tomas James
author_sort Pal, Avishek
collection PubMed
description Article-level measures of publication impact (alternative metrics or altmetrics) can help authors and other stakeholders assess engagement with their research and the success of their communication efforts. The wide variety of altmetrics can make interpretation and comparative assessment difficult; available summary tools are either narrowly focused or do not reflect the differing values of metrics from a stakeholder perspective. We created the EMPIRE (EMpirical Publication Impact and Reach Evaluation) Index, a value-based, multi-component metric framework for medical publications. Metric weighting and grouping were informed by a statistical analysis of 2891 Phase III clinical trial publications and by a panel of stakeholders who provided value assessments. The EMPIRE Index comprises three component scores (social, scholarly, and societal impact), each incorporating related altmetrics indicating a different aspect of engagement with the publication. These are averaged to provide a total impact score and benchmarked so that a score of 100 equals the mean scores of Phase III clinical trial publications in the New England Journal of Medicine (NEJM) in 2016. Predictor metrics are defined to estimate likely long-term impact. The social impact component correlated strongly with the Altmetric Attention Score and the scholarly impact component correlated modestly with CiteScore, with the societal impact component providing unique insights. Analysis of fresh metrics collected 1 year after the initial dataset, including an independent sample, showed that scholarly and societal impact scores continued to increase, whereas social impact scores did not. Analysis of NEJM ‘notable articles’ showed that observational studies had the highest total impact and component scores, except for societal impact, for which surgical studies had the highest score. The EMPIRE Index provides a richer assessment of publication value than standalone traditional and alternative metrics and may enable medical researchers to assess the impact of publications easily and to understand what characterizes impactful research.
format Online
Article
Text
id pubmed-8979442
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-89794422022-04-05 Introducing the EMPIRE Index: A novel, value-based metric framework to measure the impact of medical publications Pal, Avishek Rees, Tomas James PLoS One Research Article Article-level measures of publication impact (alternative metrics or altmetrics) can help authors and other stakeholders assess engagement with their research and the success of their communication efforts. The wide variety of altmetrics can make interpretation and comparative assessment difficult; available summary tools are either narrowly focused or do not reflect the differing values of metrics from a stakeholder perspective. We created the EMPIRE (EMpirical Publication Impact and Reach Evaluation) Index, a value-based, multi-component metric framework for medical publications. Metric weighting and grouping were informed by a statistical analysis of 2891 Phase III clinical trial publications and by a panel of stakeholders who provided value assessments. The EMPIRE Index comprises three component scores (social, scholarly, and societal impact), each incorporating related altmetrics indicating a different aspect of engagement with the publication. These are averaged to provide a total impact score and benchmarked so that a score of 100 equals the mean scores of Phase III clinical trial publications in the New England Journal of Medicine (NEJM) in 2016. Predictor metrics are defined to estimate likely long-term impact. The social impact component correlated strongly with the Altmetric Attention Score and the scholarly impact component correlated modestly with CiteScore, with the societal impact component providing unique insights. Analysis of fresh metrics collected 1 year after the initial dataset, including an independent sample, showed that scholarly and societal impact scores continued to increase, whereas social impact scores did not. Analysis of NEJM ‘notable articles’ showed that observational studies had the highest total impact and component scores, except for societal impact, for which surgical studies had the highest score. The EMPIRE Index provides a richer assessment of publication value than standalone traditional and alternative metrics and may enable medical researchers to assess the impact of publications easily and to understand what characterizes impactful research. Public Library of Science 2022-04-04 /pmc/articles/PMC8979442/ /pubmed/35377894 http://dx.doi.org/10.1371/journal.pone.0265381 Text en © 2022 Pal, Rees https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Pal, Avishek
Rees, Tomas James
Introducing the EMPIRE Index: A novel, value-based metric framework to measure the impact of medical publications
title Introducing the EMPIRE Index: A novel, value-based metric framework to measure the impact of medical publications
title_full Introducing the EMPIRE Index: A novel, value-based metric framework to measure the impact of medical publications
title_fullStr Introducing the EMPIRE Index: A novel, value-based metric framework to measure the impact of medical publications
title_full_unstemmed Introducing the EMPIRE Index: A novel, value-based metric framework to measure the impact of medical publications
title_short Introducing the EMPIRE Index: A novel, value-based metric framework to measure the impact of medical publications
title_sort introducing the empire index: a novel, value-based metric framework to measure the impact of medical publications
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979442/
https://www.ncbi.nlm.nih.gov/pubmed/35377894
http://dx.doi.org/10.1371/journal.pone.0265381
work_keys_str_mv AT palavishek introducingtheempireindexanovelvaluebasedmetricframeworktomeasuretheimpactofmedicalpublications
AT reestomasjames introducingtheempireindexanovelvaluebasedmetricframeworktomeasuretheimpactofmedicalpublications